After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Earnings were underwhelming but this stock still has value.
Put aside the earnings miss. This stock will be traveling higher soon.
St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.
The tech stock is undervalued but working to catch up to competitors in the cloud.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.